Kingdon Capital Management, L.L.C. Iovance Biotherapeutics, Inc. Put Options Transaction History

Kingdon Capital Management, L.L.C.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $8.6 Million - $15.8 Million	-300,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $8.41 Million - $15.1 Million	300,000 New	300,000 $13.9 Million
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $4.16 Million - $5.45 Million	-150,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $4.08 Million - $6.15 Million	150,000 New	150,000 $4.12 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $1.95 Million - $3.89 Million	-100,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $1.8 Million - $2.94 Million	100,000 New	100,000 $2.77 Million

316

239M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $933M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.